Abstract:Endogenous vascular endothelial growth factor (VEGF-A) can protect retinal ganglion cells (RGC) from stress-induced cell death in ocular hypertensive glaucoma. To exploit the neuroprotective function of VEGF-A for therapeutic application in ocular disorders such as glaucoma while minimizing unwanted vascular side effects, we engineered two novel VEGF variants, eVEGF-38 and eVEGF-53. These variants of the diffusible VEGF-A isoform VEGF121 are expressed as dimeric concatamers and remain tethered to the cell membrane, thus restricting the effects of the engineered VEGF to the cells expressing the protein. For comparison, we tested a Myc-tagged version of VEGF189, an isoform that binds tightly to the extracellular matrix and heparan sulfate proteoglycans at the cell surface, supporting only autocrine and localized juxtacrine signaling. In human retinal endothelial cells (hREC), expression of eVEGF-38, eVEGF-53, or VEGF189 increased VEGFR2 phosphorylation without increasing expression of pro-inflammatory markers, relative to VEGF165 protein and vector controls. AAV2-mediated transduction of eVEGF-38, eVEGF-53, or VEGF189 into primary mouse RGC promoted synaptogenesis and increased the average total length of neurites and axons per RGC by ~ 12-fold, an increase that was mediated by VEGFR2 and PI3K/AKT signaling. Expression of eVEGF-38 in primary RGC enhanced expression of genes associated with neuritogenesis, axon outgrowth, axon guidance, and cell survival. Transduction of primary RGC with any of the membrane-associated VEGF constructs increased survival both under normal culture conditions and in the presence of the cytotoxic chemicals H 2 O 2 (via VEGFR2/PI3K/AKT signaling) and N -methyl- d -aspartate (via reduced Ca 2+ influx). Moreover, RGC number was increased in mouse embryonic stem cell-derived retinal organoid cultures transduced with the eVEGF-53 construct. The novel, engineered VEGF variants eVEGF-38 and eVEGF-53 show promise as potential therapeutics for retinal RGC neuroprotection when delivered using a gene therapy approach.

[Preparation of Genetically Engineered Retinal Pigment Epithelial Cells Capable of Secreting Nerve Growth Factor].

Usingneurogeninto Reprogram Chick RPE to Produce Photoreceptor-like Neurons

Transfection and expression of retrovirus-mediated reporter genes in retinal pigment epithelial cells in vitro

Rapid and Efficient Generation of a Transplantable Population of Functional Retinal Ganglion Cells from Fibroblasts.

[Subretinal Transplantation of Genetically Modified Human Retinal Pigment Epithelium Cells Delay Photoreceptor Degeneration and Functional Deterioration in Rats].

BDNF gene delivery to the retina by cell adhesion peptide-conjugated gemini nanoplexes in vivo

Cloning of the Eukaryotic Expression Vector with Nerve Growth Factor in Rats and Its Effects on Proliferation and Differentiation of Mesencephal Neural Stem Cells of Fetal Rats

[The Preliminary Experiment of Gene Transfer into Cultured Rat Retinal Neural Cells].

Dermal Fibroblasts Genetically Engineered to Release Nerve Growth Factor

Efficient retinal ganglion cells transduction by retro-orbital venous sinus injection of AAV-PHP.eB in mature mice

Novel engineered, membrane-localized variants of vascular endothelial growth factor (VEGF) protect retinal ganglion cells: a proof-of-concept study

Basic fibroblast growth factor gene transferred into retinal ganglion cells by in vivo electroporation prevents photoreceptor degeneration in RCS rats

Transfection of Schwann cells with retrovirus pLNCX2-GDNF and its expression

Peripheral Nerve and Transgene Cells Transplantation in the Treatment of Experimental Neuropathy of SD Rats.

Establishment of superparamagnetic iron oxide and enhanced green fluorescence protein double labeled nerve growth factor gene modified midbrain derived neural stem cells

Rescue of Photoreceptors by BDNF Gene Transfer Using in Vivo Electroporation in the RCS Rat of Retinitis Pigmentosa.

[Silenced NgR Gene Expression by RNA Interference to Promote Rats Facial Nerve Regeneration in Vitro].

In situ regeneration of retinal pigment epithelium by gene transfer of E2F2: a potential strategy for treatment of macular degenerations

Construction of Lentivirus-Mediated Retinal Pigment Epithelium Cells Stably Expressing Basic Fibroblast Growth Factors

The study of transfection protein to rat retinal stem cells

Enriching new transplantable RGC-like cells from retinal organoids for RGC replacement therapy